Orthofix Medical (OFIX) Other financing activities (2010 - 2026)

Orthofix Medical has disclosed Other financing activities across 16 years of filings, most recently posting $24000.0 for Q1 2026.

• Quarterly Other financing activities fell 95.31% year-over-year to $24000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (down 98.34% YoY) and the FY2025 annual result came in at $531000.0, down 85.37% from the prior year.
• Other financing activities improved to $24000.0 in Q1 2026, from $19000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $1.7 million in Q4 2023 and troughed at -$23000.0 in Q1 2022.
• A 5-year average of $488769.2 and a median of $225000.0 in 2024 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2023 — Other financing activities surged 1921.74% — and 2025, when it plunged 97.75%.
• Tracing OFIX's Other financing activities over 5 years: stood at $160000.0 in 2022, then jumped by 936.25% to $1.7 million in 2023, then tumbled by 38.9% to $1.0 million in 2024, then plunged by 98.12% to $19000.0 in 2025, then advanced by 26.32% to $24000.0 in 2026.
• Business Quant data shows OFIX's Other financing activities at $24000.0 in Q1 2026, $19000.0 in Q2 2025, and $512000.0 in Q1 2025.